Skip to main content
. 1998 Jan 26;1998(1):CD001044. doi: 10.1002/14651858.CD001044

Gagliardi 1983.

Methods Double blinded: 
 yes.
Participants N=40 Italian men with symptomatic BPH. Age range: 50‐84, mean 67 years. Lost to follow‐up: 1 (2.5%).
Interventions Control: Anti‐inflammatory 
 (not identified) (n=20) 
 Treatment: P. africanum extract (Tadenan) 100 mg daily (n=20). 
 Treatment duration: 30 days.
Outcomes Nocturia; residual volume. Adverse events.
Notes  
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Unclear risk B ‐ Unclear